Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2026 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Fennec Pharmaceuticals First Quarter 2026 Earnings and Corporate Update Conference Call.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Southpoint Capital Advisors John Smith Clark | 2,744,741 | $16,880,157 | 0.35% | |
| 2. | Solas Capital Management Frederick Tucker Golden | 2,482,198 | $15,265,518 | -4% | 8.78% |
| 3. | AIGH Investment Partners Orin Hirschman | 1,981,501 | $12,186,231 | +26% | 1.66% |
| 4. | Potomac Capital Management Paul Solit And Eric Singer | 224,400 | $1,380,060 | +136% | 1.2% |
| 5. | Citadel Investment Group Ken Griffin | 153,610 | $944,702 | -24% | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.99 | 13,965 | $97,615.35 | 15,000 | 2025-05-19 | Filing | |
| $6.75 | 1,035 | $6,986.25 | 1,035 | 2025-05-16 | Filing | |
| $0.00 | 12,500 | $0.00 | 104,271 | 2024-04-01 | Filing | |
| $0.00 | 29,167 | $0.00 | 316,638 | 2024-04-01 | Filing | |
| $6.25 | 80,000 | $500,000.00 | 4,077,214 | 2020-05-04 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.62 | 9,747 | $93,766.14 | 130,079 | 2026-06-01 | Filing | |
| $7.04 | 8,346 | $58,755.84 | 63,077 | 2026-05-11 | Filing | |
| $6.47 | 10,781 | $69,753.07 | 121,451 | 2026-05-01 | Filing | |
| $6.31 | 10,946 | $69,069.26 | 113,856 | 2026-04-01 | Filing | |
| $8.36 | 10,079 | $84,260.44 | 103,996 | 2026-03-02 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,908,201 | $17,885,436 | 7.19% | |
| 2. | 1,368,176 | $8,414,284 | 0% | |
| 3. | 897,144 | $5,517,436 | 0% | |
| 4. | 720,135 | $4,428,830 | 0.49% | |
| 5. | 371,738 | $2,286,188 | 0% |